| Financial Year |
March 31 2023 |
| Monetary Funds |
2,253,570,763.28 |
| Held-for-trading Financial Assets |
538,143,961.22 |
| Notes Receivable |
5,907,396.61 |
| Accounts Receivable |
1,162,450,229.79 |
| Advances to Suppliers |
237,726,178.58 |
| Other Receivables |
82,705,006.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,189,804,423.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
5,521,319,404.15 |
| Other Current Assets |
4,744,725,240.63 |
| Total Current Assets |
16,749,852,604.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,251,279,655.42 |
| Investment Properties |
616,444,121.95 |
| Fixed Assetes |
5,874,089,993.55 |
| Under-construction Projects |
388,805,715.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
780,773,295.80 |
| R&D expenses |
-- |
| Goodwill |
82,738,243.38 |
| Long-Term Deferred and Prepaid Expenses |
369,137,786.01 |
| Deferred Income Tax Assets |
26,162,551.79 |
| Other Non-Current Assets |
3,841,798,087.77 |
| Sub-Total of Non-Current Assets |
13,575,785,623.76 |
| Total Assets |
30,325,638,228.06 |
| Short-Term Loans |
8,028,588.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,501,487.16 |
| Accounts Payable |
5,855,703,558.64 |
| Accounts Received In Advance |
82,949,188.53 |
| Employee Compensation Payable |
353,574,480.93 |
| Taxes Payable |
25,569,337.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
701,457,772.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
88,211,196.90 |
| Other Current Liabilities |
27,573,499.38 |
| Sub-Total of Current Liabilities |
10,820,349,651.32 |
| Long-term Loans |
127,361,238.51 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
595,260,392.70 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,460,498,127.50 |
| Total Liabilities |
12,280,847,778.82 |
| Paid-In Capital(Or Share Stock) |
2,544,900,000.00 |
| Capital Surplus |
3,152,725,641.60 |
| Surplus Reserve |
2,378,865,629.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,584,228,273.28 |
| Minority Stockholder's Interest |
310,874,971.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,733,915,477.55 |
| Owner's Equity（Stockholder's Equity） |
18,044,790,449.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
30,325,638,228.06 |
